INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 26 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,000 | -46.2% | 27,300 | -40.5% | 0.00% | – |
| Q2 2020 | $13,000 | +85.7% | 45,906 | +31.0% | 0.00% | – |
| Q1 2020 | $7,000 | +600.0% | 35,046 | +3065.9% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 1,107 | -31.2% | 0.00% | – |
| Q3 2019 | $1,000 | -80.0% | 1,610 | +36.0% | 0.00% | – |
| Q2 2019 | $5,000 | -98.3% | 1,184 | -97.0% | 0.00% | – |
| Q1 2019 | $290,000 | -27.1% | 39,515 | -25.2% | 0.00% | – |
| Q4 2018 | $398,000 | – | 52,845 | +105590.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 50 | -99.8% | 0.00% | – |
| Q2 2018 | $104,000 | -48.3% | 23,740 | -25.4% | 0.00% | – |
| Q1 2018 | $201,000 | +44.6% | 31,819 | +18.1% | 0.00% | – |
| Q4 2017 | $139,000 | -51.9% | 26,948 | -16.6% | 0.00% | – |
| Q3 2017 | $289,000 | +5680.0% | 32,312 | +3592.8% | 0.00% | – |
| Q4 2016 | $5,000 | +25.0% | 875 | +37.6% | 0.00% | – |
| Q3 2016 | $4,000 | -63.6% | 636 | -72.9% | 0.00% | – |
| Q2 2016 | $11,000 | -8.3% | 2,346 | -19.2% | 0.00% | – |
| Q1 2016 | $12,000 | -45.5% | 2,902 | -29.3% | 0.00% | – |
| Q4 2015 | $22,000 | +214.3% | 4,102 | +216.5% | 0.00% | – |
| Q3 2015 | $7,000 | – | 1,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |